Overview

A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)

Status:
RECRUITING
Trial end date:
2027-01-28
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is evaluate the effect of brensocatib compared with placebo.
Phase:
PHASE2
Details
Lead Sponsor:
Insmed Incorporated
Treatments:
brensocatib